Completed PHASE2 INTERVENTIONAL 2-arm NCT01448213

Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)

Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty

Sponsor: Price Vision Group

Conditions Bullous Keratopathy Fuchs' Dystrophy

Interventions Fluorometholone Prednisolone acetate

Updated 6 times since 2017 Last updated: Aug 22, 2014 Started: Oct 31, 2011 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01448213, this PHASE2 trial focuses on Bullous Keratopathy and Fuchs' Dystrophy and remains completed. Sponsored by Price Vision Group, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Price Vision Group

Data source: Price Vision Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany
• Indianapolis, United States